Short term complications of endoscopic retrograde cholangiopancreatography;Complications à court terme de la cholangio-pancréatographie rétrograde endoscopique (CPRE) diagnostique et thérapeutique

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 11, 2002, Pages 980-987

  Barthet, Marc ^a   Heyries, Laurent ^b   Desjeux, Ariadne ^a  

^a HÔPITAL NORD   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; HUMAN; IATROGENIC DISEASE; PREVALENCE; RISK FACTOR; SPHINCTEROTOMY;

ACUTE DISEASE; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLELITHIASIS; CHRONIC DISEASE; COMMON BILE DUCT NEOPLASMS; HEMORRHAGE; HUMANS; IATROGENIC DISEASE; MULTICENTER STUDIES; ODDS RATIO; PANCREATITIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SPHINCTER OF ODDI; SPHINCTEROTOMY, ENDOSCOPIC; TIME FACTORS;

EID: 0036861921     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Fournet J, Dhumeaux D, L'endoscopie. In: SNFGE, eds. Le Livre Blanc de L'Hépato-Gastroentérologie. Paris: Masson, 2001:155-7.
2. Heyries L, Barthet M, Miranda C, Bernard JP, Sahel J. Intubation pancréatique per endoscopique dans la pancréatite chronique calcifiante. Gastroenterol Clin Biol 1999;23:469-76.
3. Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988;2:979-83.
4. Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993;328:228-32.
5. Folsch UR, Nitsche R, Ludtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med 1997;336:237-42.
6. Berdah SV, Orsoni P, Bege T, Barthet M, Grimaud JC, Picaud R. Follow-up of selective endoscopic ultrasonography and/or endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy: A prospective study of 300 patients. Endoscopy 2001;33:216-20.
7. Suc B, Escat J, Cherqui D, Fourtanier G, Hay JM, Fingerhut A, et al. Surgery vs endoscopy as primary treatment in symptomatic patients with suspected common bile duct stones: A multicenter randomized trial. French Associations for Surgical Research. Arch Surg 1998;133:702-8.
8. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
9. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
10. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am J Gastroenterol 2001;96:417-23.
11. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di F. V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996;335:919-23.
12. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis. Gastrointest Endosc 2000;51:1-7.
13. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
14. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37:383-93.
15. Cotton PB. Outcomes of endoscopy procedures: Struggling towards definitions. Gastrointest Endosc 1994;40:514-8.
16. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
17. Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: A prospective series of claims to insurance covering public hospitals. Endoscopy 1999;31:125-30.
18. Classen M, Demling L. [Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)]. Dtsch Med Wochenschr 1974;99:496-7.
19. Kawai K, Akasaka Y, Murakami K, Tada M, Koli Y. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc 1974;20:148-51.
20. Bergman JJ, Rauws EA, Fockens P, van Berkel AM, Bossuyt PM, Tijssen JG, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet 1997;349:1124-9.
21. Bergman JJ, van Berkel AM, Bruno MJ, Fockens P, Rauws EA, Tijssen JG, et al. Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? Endoscopy 2001;33:416-20.
22. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
23. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med 1989;320:82-7.
24. Rabenstein T, Schneider HT, Bulling D, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: Preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 2000;32:10-9.
25. Freeman ML. Complications of endoscopic sphincterotomy. Endoscopy 1998;30:A216-A220.
26. Fuji T, Amano H, Harima K, Aibe T, Asagami F, Kinukawa K, et al. Pancreatic sphincterotomy and pancreatic endoprosthesis. Endoscopy 1985;17:69-72.
27. Kozarek RA, Ball TJ, Patterson DJ, Brandabur JJ, Traverso LW, Raltz S. Endoscopic pancreatic duct sphincterotomy: Indications, technique, and analysis of results. Gastrointest Endosc 1994;40:592-8.
28. Fuji T, Amano H, Ohmura R, Akiyama T, Aibe T, Takemoto T. Endoscopic pancreatic sphincterotomy - Technique and evaluation. Endoscopy 1989;21:27-30.
29. Huibregtse K, Schneider B, Vrij AA, Tytgat GN. Endoscopic pancreatic drainage in chronic pancreatitis. Gastrointest Endosc 1988;34:9-15.
30. Grimm H, Meyer WH, Nam VC, Soehendra N. New modalities for treating chronic pancreatitis. Endoscopy 1989;21:70-4.
31. Kozarek RA, Patterson DJ, Ball TJ, Traverso LW. Endoscopic placement of pancreatic stents and drains in the management of pancreatitis. Ann Surg 1989;209:261-6.
32. Kim MH, Myung SJ, Kim YS, Kim HJ, Seo DW, Nam SW, et al. Routine biliary sphincterotomy may not be indispensable for endoscopic pancreatic sphincterotomy. Endoscopy 1998;30:697-701.
33. Sherman S, Lehman GA. Endoscopic pancreatic sphincterotomy: Techniques and complications. Gastrointest Endosc Clin N Am 1998;8:115-24.
34. Okolo PI, Pasricha PJ, Kalloo AN. What are the long-term results of endoscopic pancreatic sphincterotomy? Gastrointest Endosc 2000;52:15-9.
35. Elton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: Indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998;47:240-9.
36. Lesavre N, Barthet M, Gasmi M, Bellon P, Desjeux A, Barrière N, et al. Facteur de risque des sphinctérotomies endoscopiques et précoupes papillaires: Étude monocentrique de 1159 CPRE consécutives (abstract). Endoscopy 2001;33:A8.
37. Kim HJ, Kim MH, Kim DI, Lee HJ, Myung SJ, Yoo KS, et al. Endoscopic hemostasis in sphincterotomy-induced hemorrhage: Its efficacy and safety. Endoscopy 1999;31:431-6.
38. Zissin R, Shapiro-Feinberg M, Oscadchy A, Pomeranz I, Leichtmann G, Novis B. Retroperitoneal perforation during endoscopic sphincterotomy: Imaging findings. Abdom Imaging 2000;25:279-82.
39. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, et al. Post-ERCP pancreatitis: Randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994;40:422-7.
40. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O. Evaluation of post-ERCP pancreatitis: Potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 1997;46:217-22.
41. Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, et al. A comparison of nonionic versus ionic contrast media: Results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 1995;42:312-6.
42. Hastier P. La pancréatite aiguë post-CPRE peut-elle être prédite et prévenue? Gastroenterol Clin Biol 2001;25:1S140-50.
43. Arnold JC, Benz C, Martin WR, Adamek HE, Riemann JF. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: A prospective randomized pilot study. Endoscopy 2001;33:563-7.
44. Cipolletta L, Costamagna G, Bianco MA, Rotondano G, Piscopo R, Mutignani M, et al. Endoscopic mechanical lithotripsy of difficult common bile duct stones. Br J Surg 1997;84:1407-9.
45. Hochberger J, Bayer J, May A, Muhldorfer S, Maiss J, Hahn EG, et al. Laser lithotripsy of difficult bile duct stones: Results in 60 patients using a rhodamine 6G dye laser with optical stone tissue detection system. Gut 1998;43:823-9.
46. Cremer M, Deviere J, Delhaye M, Baize M, Vandermeeren A. Stenting in severe chronic pancreatitis: Results of medium-term follow-up in seventy-six patients. Endoscopy 1991;23:171-6.
47. Ponchon T, Bory RM, Hedelius F, Roubein LD, Paliard P, Napoleon B, et al. Endoscopic stenting for pain relief in chronic pancreatitis: Results of a standardized protocol. Gastrointest Endosc 1995;42:452-6.
48. Siegel J, Veerappan A. Endoscopic management of pancreatic disorders: Potential risks of pancreatic prostheses. Endoscopy 1991;23:177-80.
49. Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992;38:341-6.
50. McCarthy J, Geenen JE, Hogan WJ. Preliminary experience with endoscopic stent placement in benign pancreatic diseases. Gastrointest Endosc 1988;34:16-8.
51. Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990;36:93-5.
52. Smith MT, Sherman S, Ikenberry SO, Hawes RH, Lehman GA. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996;44:268-75.
53. Sherman S, Hawes RH, Savides TJ, Gress FG, Ikenberry SO, Smith MT, et al. Stent-induced pancreatic ductal and parenchymal changes: Correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 1996;44:276-82.
54. Dohmoto M, Rupp KD. Endoscopic drainage of pancreatic pseudocysts. Surg Endosc 1992;6:118-24.
55. Smits ME, Rauws EA, Tytgat GN, Huibregtse K. The efficacy of endoscopic treatment of pancreatic pseudocysts. Gastrointest Endosc 1995;42:202-7.
56. Kozarek RA, Ball TJ, Patterson DJ, Freeny PC, Ryan JA, Traverso LW. Endoscopic transpapillary therapy for disrupted pancreatic duct and peripancreatic fluid collections. Gastroenterology 1991;100:1362-70.
57. Barthet M, Sahel J, Bodiou-Bertei C, Bernard JP. Endoscopic transpapillary drainage of pancreatic pseudocysts. Gastrointest Endosc 1995;42:208-13.
58. Catalano MF, Geenen JE, Schmalz MJ, Johnson GK, Dean RS, Hogan WJ. Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc 1995;42:214-8.
59. Binmoeller KF, Seifert H, Walter A, Soehendra N. Transpapillary and transmural drainage of pancreatic pseudocysts. Gastrointest Endosc 1995;42:219-24.
60. Huibregtse K, Katon RM, Coene PP, Tytgat GN. Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc 1986;32:334-8.
61. Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial. Br J Surg 1988;75:1166-8.
62. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994;344:1655-60.
63. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-92.
64. Prat F, Chapat O, Ducot B, Ponchon T, Pelletier G, Fritsch J, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998;47:1-7.
65. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-62.
66. Born P, Rosch T, Bruhl K, Sandschin W, Weigert N, Ott R, et al. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol 2000;38:483-9.
67. Dumas R, Demuth N, Buckley M, Peten EP, Manos T, Demarquay JF, et al. Endoscopic bilateral metal stent placement for malignant hilar stenoses: Identification of optimal technique. Gastrointest Endosc 2000;51:334-8.
68. Hastier P, Buckley MJ, Peten EP, Demuth N, Dumas R, Demarquay JF, et al. A new source of drug-induced acute pancreatitis: Codeine. Am J Gastroenterol 2000;95:3295-8.
69. Smithies AM, Sargen K, Demaine AG, Kingsnorth AN. Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 2000;20:234-40.
70. Bordas JM, Toledo-Pimentel V, Llach J, Elena M, Mondelo F, Gines A, et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: Results of a randomized study. Gastrointest Endosc 1998;47:230-4.
71. Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial. Gastrointest Endosc 1999;49:593-8.
72. Huang J, Padbury RT, Schloithe AC, Cox MR, Simula ME, Harvey JR, et al. Somatostatin stimulates the brush-tailed possum sphincter of Oddi in vitro and in vivo. Gastroenterology 1998;115:672-9.
73. Testoni PA, Lella F, Bagnolo F, Caporuscio S, Cattani L, Colombo E, et al. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla. Pancreas 1996;13:61-5.
74. Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1992;87:1561-6.
75. Subhani JM, Kibbler C, Dooley JS. Review article: Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999;13:103-16.
76. Harris A, Chan AC, Torres-Viera C, Hammett R, Carr-Locke D. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31:718-24.
77. Lorenz R, Herrmann M, Kassem AM, Lehn N, Neuhaus H, Classen M. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system. Endoscopy 1998.